Skip to content
Search

Latest Stories

NHS of tomorrow must capitalise on community pharmacy’s potential – CPE

NHS 10-Year Plan
Pharmacy (gettyimages)

'Community pharmacy can effectively support the government’s three shifts if funding for the sector is stabilised'

Community Pharmacy England (CPE) has submitted proposals for NHS 10-Year Plan, highlighting economic stabilisation of the sector, making Pharmacy First a walk-in service, and regulatory changes to enable pharmacists to better deal with medicines shortages as “quick and crucial ways” to improve the current situation.

In October, the health secretary launched a national conversation, seeking input and ideas to shape the future of the health service via the change.nhs.uk portal. Healthcare organisations were also invited to make formal submissions.


In their submission, the CPE emphasised the need for the NHS to leverage pharmacy's potential to identify “people with undiagnosed conditions and support behaviour changes to reduce the future likelihood of ill health.”

The organisation also underscored the importance of addressing the sector’s current funding gap, noting that “community pharmacy is lagging behind funding uplifts given to the rest of the NHS.”

In its response, the CPE states: “Community pharmacies can effectively support the Government’s three shifts, enhancing access to care for all patients, including those less well served by other parts of the NHS, supporting work to prevent ill health and providing improved outcomes for individuals and the NHS, but in order to achieve this, it is necessary for the NHS funding for the sector to be stabilised.”

CPE chief executive Janet Morrison emphasised the critical timing of the NHS plan, noting its significance for community pharmacies, which are in “an ever-more precarious position.”

She said: “Our overarching aim is to see increased commissioning of pharmacy services for the benefit of patients, the public and the wider NHS.

“But this cannot happen without first resolving the critical need for investment in community pharmacies, as well as a more supportive regulatory structure and better collaboration across the whole health service.”

Furthermore, Morrison noted that the NHS of tomorrow must capitalise on “community pharmacy’s USP – easily accessible healthcare advice and treatment close to where people live, shop and work – to help meet the government’s ambition to shift the focus of healthcare towards prevention.”

Community Pharmacy England's key proposals include: putting community pharmacies at the centre of primary care delivery, investing in the long-term stability of the sector, preventing closures, ensuring a supportive regulatory framework, expanding commissioned services, and promoting collaboration across primary care.

Sector facing significant funding pressures

The organisation also pointed out that the current funding model is “unsustainable and risks undermining efforts to embed Pharmacy First while putting core dispensing and supply services at risk.”

Community pharmacy funding has reduced from £2.8bn in 2015/16 to £2.592bn in 2023/24.

“The reduction in funding is causing pharmacies to close, totalling over 1,400 since the funding cut took effect,” it said.

The CPE’s Pharmacy Pressures Survey 2024 revealed that the trend in pharmacy closures is accelerating with an average of 10 pharmacies closing per week in the first four months of 2024, nearly 50 per cent higher than the same period in 2023.

One in six respondents stated that they are unlikely to remain open in a year and 64 per cent of pharmacy premises reported operating at a loss.

Over half of pharmacy staff surveyed reported that patients are being negatively affected as a result of these pressures.

CPE also proposes expanding Pharmacy First, vaccination programs, and women’s health services to shift more care from hospitals to community settings.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less